Antimicrobial resistance (AMR) is one of the most consequential threats to global health, undermining decades of progress in infection control, surgery, cancer care, and maternal-child health.
As bacteria, viruses, fungi, and parasites evolve to withstand medicines designed to kill them, common infections become harder and costlier to treat — with ripple effects across health systems, economies, and communities.
What drives antimicrobial resistance
– Overuse and misuse of antibiotics in human medicine, such as unnecessary prescriptions for viral illnesses, accelerate resistance.
– Widespread use of antimicrobials in agriculture and aquaculture for growth promotion and disease prevention contributes to resistant strains that can spread to humans.
– Limited access to high-quality diagnostics leads clinicians to prescribe broad-spectrum drugs “just in case,” further selecting for resistant organisms.
– A thin pipeline of new antibiotics and antifungals reduces options when resistance emerges; commercial incentives for novel antimicrobials remain weak.
– Poor infection prevention and control, plus gaps in water, sanitation, and hygiene (WASH), enable resistant pathogens to spread in communities and health facilities.
Strategies that work
A One Health response recognizes that human, animal, and environmental health are interconnected and must be addressed together. Key interventions include:
1. Strengthen antimicrobial stewardship
Implement stewardship programs across hospitals, clinics, and community settings to ensure antibiotics are prescribed only when needed, at the right dose and duration. Stewardship combines clinician education, prescribing guidelines, and audit-feedback systems.
2. Scale up rapid diagnostics and genomic surveillance
Accurate, affordable diagnostics reduce unnecessary antibiotic use by distinguishing bacterial from viral infections. Genomic surveillance and wastewater monitoring help detect emerging resistance patterns early, guiding public health action and treatment recommendations.
3.
Invest in infection prevention and WASH
Robust infection control in healthcare facilities and improved water, sanitation, and hygiene in communities reduce the incidence of infections and therefore the need for antimicrobials. Vaccination programs also lower disease burden and antibiotic consumption.
4. Reform agricultural practices
Promote responsible use of antimicrobials in livestock and aquaculture, adopt alternatives for disease prevention (biosecurity, vaccination), and phase out non-therapeutic uses that drive resistance.
5. Incentivize research and equitable access
Public-private partnerships and innovative financing mechanisms can stimulate antibiotic development while ensuring new medicines are used judiciously. Models that separate sales volumes from developer returns (delinkage) help balance access with conservation. Equitable access to existing and new antimicrobials is crucial for low-resource settings.
6. Strengthen governance and global coordination
National action plans aligned with international frameworks enable coordinated surveillance, data sharing, and policy coherence.
Cross-border collaboration is essential because resistant pathogens do not respect borders.
What individuals and communities can do
– Use antibiotics only when prescribed and complete the full course unless directed otherwise.
– Never share or use leftover antibiotics.
– Practice good hygiene, stay updated on recommended vaccines, and seek rapid testing when available.
– Support local efforts to improve sanitation and reduce unnecessary antibiotic use in food production.
Why action matters
Unchecked AMR threatens to make routine surgeries and many medical treatments riskier, lengthen hospital stays, and increase healthcare costs. Progress depends on aligning policy, finance, health systems, agriculture, and public behavior around prevention, smart use, and innovation. Coordinated action today preserves the effectiveness of lifesaving medicines for generations to come.